135 related articles for article (PubMed ID: 38308154)
1. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study.
Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ
J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
[TBL] [Abstract][Full Text] [Related]
3. Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.
McDermott A; Kim N; Hausmann LRM; Magnani JW; Good CB; Litam TMA; Mor MK; Omole TD; Gellad WF; Fine MJ; Essien UR
J Gen Intern Med; 2023 Mar; 38(4):848-856. PubMed ID: 36151447
[TBL] [Abstract][Full Text] [Related]
4. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
5. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
[TBL] [Abstract][Full Text] [Related]
6. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
7. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries.
Reynolds KR; Khosrow-Khavar F; Dave CV
JAMA Netw Open; 2024 May; 7(5):e249465. PubMed ID: 38709533
[TBL] [Abstract][Full Text] [Related]
9. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
10. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
11. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.
Derington CG; Goodrich GK; Xu S; Clark NP; Reynolds K; An J; Witt DM; Smith DH; O'Keeffe-Rosetti M; Lang DT; Ho PM; Cheetham TC; Comer AC; King JB
JAMA Netw Open; 2023 Jul; 6(7):e2321971. PubMed ID: 37410461
[TBL] [Abstract][Full Text] [Related]
12. Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees.
Wong ES; Done N; Zhao M; Woolley AB; Prentice JC; Mull HJ
J Manag Care Spec Pharm; 2021 Aug; 27(8):1056-1066. PubMed ID: 34337995
[No Abstract] [Full Text] [Related]
13. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
[TBL] [Abstract][Full Text] [Related]
14. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.
Bhave PD; Lu X; Girotra S; Kamel H; Vaughan Sarrazin MS
Heart Rhythm; 2015 Jul; 12(7):1406-12. PubMed ID: 25814418
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
[TBL] [Abstract][Full Text] [Related]
16. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
[TBL] [Abstract][Full Text] [Related]
18. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
[TBL] [Abstract][Full Text] [Related]
19. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
[TBL] [Abstract][Full Text] [Related]
20. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
